Form 4: Intuitive Surgical SVP Henry L. Charlton Executes Stock Options and Sells Shares Under 10b5-1 Plan

Sentiment:

SEC Form 4


Henry L. Charlton, SVP & Chief Commercial and Marketing Officer of Intuitive Surgical, exercised stock options and sold shares of common stock on August 23, 2024, under a pre-arranged 10b5-1 trading plan.

Summary

  • On August 23, 2024, Henry L. Charlton, SVP & Chief Commercial and Marketing Officer of Intuitive Surgical Inc. (ISRG), executed multiple non-qualified stock options and sold corresponding shares of common stock.
  • The transactions were conducted under a pre-arranged trading plan that complies with SEC Rule 10b5-1, set to expire on May 26, 2025.
  • Charlton acquired a total of 23,954 shares through option exercises at prices ranging from $59.4622 to $182.8333.
  • He then sold a total of 41,528 shares at a weighted average price of $486.8374, with individual transactions ranging from $480.23 to $493.48.
  • Following these transactions, Charlton directly owns 23,486 shares of common stock.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the document simply reports stock transactions by an executive under a pre-existing plan. There is no indication of positive or negative implications for the company.

Positives

  • The transactions were conducted under a pre-arranged 10b5-1 trading plan, indicating that the sales were planned and not based on any inside information.

Industry Context

Executive stock transactions are a common occurrence in publicly traded companies. Monitoring these transactions can provide insights into management's perspective on the company's valuation and future prospects. The use of a 10b5-1 plan suggests a pre-determined strategy for these transactions.

Comparison to Industry Standards

  • Executive compensation and stock option plans are standard practice among publicly traded companies, particularly in the technology and healthcare sectors.
  • Companies like Medtronic, Stryker, and Johnson & Johnson also utilize stock options as part of their executive compensation packages.
  • The vesting schedules and exercise prices are generally aligned with industry norms to incentivize long-term performance and retention.

Stakeholder Impact

  • The transactions may have a minor impact on shareholders due to the change in ownership, but the pre-planned nature of the sales mitigates concerns about insider information.

Key Dates

DateDescription
08/15/2026Expiration date for some non-qualified stock options.
02/15/2027Expiration date for some non-qualified stock options.
08/15/2027Expiration date for some non-qualified stock options.
02/15/2028Expiration date for some non-qualified stock options.
08/15/2028Expiration date for some non-qualified stock options.
02/15/2029Expiration date for some non-qualified stock options.
08/15/2029Expiration date for some non-qualified stock options.
05/26/2025Expiration date of the 10b5-1 trading plan.
08/23/2024Date of the stock option exercises and share sales.
08/26/2024Date of the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.